Patient-Reported Outcome Questionnaire Shows Promise for Monitoring ITP – ASH Clinical News
Patient-Reported Outcome Questionnaire Shows Promise for Monitoring ITP – Bleeding Disorders, Literature Scan, News – ASH Clinical News
Patient-Reported Outcome Questionnaire Shows Promise for Monitoring ITP – Bleeding Disorders, Literature Scan, News – ASH Clinical News
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. Patients with previously untreated chronic lymphocytic leukemia (CLL) who receive one-year fixed-duration treatment…
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Treatment with teclistamab in patients with relapsed or refractory multiple…
Lara C. Pullen, PhD, is a freelance medical writer in Chicago, Illinois. A long-term retrospective study by Zhuo-Fan Xu, MD, of the Chinese Academy of…
ASH Clinical News Editor-in-Chief Aaron Gerds, MD, previews what’s to come in November. Highlights include a feature on managing substance use disorders in p…
Ruth Jessen Hickman, MD, is a freelance medical and science writer based in Bloomington, Indiana. Rec ent data from the first randomized trial on hydroxyurea…
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. The majority of patients with iron deficiency did not have…
Katie Robinson is a medical writer based in New York. Contrary to current insight, the incidence of monoclonal gammopathy of undetermined significance (MGUS) was similar…
Leah Lawrence is a freelance health writer and editor based in Delaware. The phase III MATTERHORN trial comparing roxadustat with placebo in patients with transfusion-dependent,…
Katie Robinson is a medical writer based in New York. NOTCH1 gene fusions in the T-cell receptor ß (TRB) were identified in some children with…
The U.S. Food and Drug Administration (FDA) granted denileukin diftitox-cxdl approval for the treatment of relapsed or refractory (R/R) cutaneous T-cell lymphoma (CTCL) after at…